28 Mar 2017 | 12:45 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
774.10
4.35
(0.57 %)
28 Mar 2017 | 12:35 PM
Change company
  • Open (Rs)
    780.60
  • Prev. close (Rs.)
    769.75
  • High (Rs.)
    785.60
  • Low (Rs.)
    771.00
  • 52W H (Rs.)
    830.00
  • 52W L (Rs.)
    390.00
  • Volume (Rs.)
    6837
  • MCap (Rs in Cr.)
    13,493.19
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
8.91
Operating Margin (%)
23.62
Gross Profit Margin (%)
19.16
Net Profit Margin (%)
13.59
Total Debt/Equity
0.08
Dividend payout Ratio (Net Profit)
16.88
Earning Retention Ratio
83.49

News

31 Jan 2017 - 12:25:00-Drug maker Natco Pharma Ltd on Tuesday said that the US District Court has ruled in favour of Mylan ...
25 Jan 2017 - 11:54:00-Natco Pharma today said the US health regulator has made six observations after the completion of in...
06 Jan 2017 - 14:36:00-Natco Pharma Ltd today said it has received final approval from USFDA for Bendamustine injection...
02 Jan 2017 - 17:04:00-Drug maker Natco Pharma Ltd on Monday said it has launched the first generic version of Sofosbuvir 4...

Announcements

16-Feb-2017
Natco Pharma - Investor Presentation
14-Feb-2017
Natco Pharma - Announces Q3 results (Standalone & Consolidated) Limited Review Report (Standalone & Consolidated) & Results
14-Feb-2017
Natco Pharma - Board declares Second Interim Dividend
14-Feb-2017
Natco Pharma - Fixes Record Date for Interim Dividend
14-Feb-2017
Natco Pharma - Results Press Release for December 31 2016

Religare Research

27 Mar 2017 | 07:13 PM
Gold prices retraced gains late Friday but still notched up a second weekly rise as concerns over th...
27 Mar 2017 | 06:00 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
27 Mar 2017 | 12:13 PM
Agri Fundamental and Technical report
27 Mar 2017 | 11:01 AM
• Gold registered second weekly rise in a row • Oil gyrated as rising US drilling offset OPEC-led cu...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 30.70 -9.79
4,00,000 90.05 129.77 -0.71
4,00,000 90.05 135.20 -0.71
4,00,000 90.05 49.20 -0.71
1,60,000 35.89 101.79 -1.09

Shareholding Pattern

       
Promotors51.24%
Mutual Funds/UTI5.33%
FI/Banks3.92%
Insurance3.92%
FII16.76%
Government0.00%
Others3.50%

Peer Group

Company Intraday Graph
 Sanofi India Ltd.
4,734.00(1.04)
3325
 GlaxoSmithKline Pharmaceuticals Ltd.
2,724.05(-0.49)
3317
 Dr. Reddy`s Laboratories Ltd.
2,634.95(-0.14)
3294
 Alkem Laboratories Ltd.
2,208.00(-0.02)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-48.60190.10155.60
NIFTY(S&P CNX)208.401,072.25398.70
BSE SENSEX602.713,202.151,191.89
BSE 500330.911,706.08690.89

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
Natco House Road No.2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Natco Pharma Ltd. that will help you decide whether to buy, sell or hold Natco Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Natco Pharma Ltd.